O6-methylguanine-DNA methyltransferase (MGMT), which is downregulated in G34 mutant DHG, paradoxically increases tumor vulnerability to alkylating agents like temozolomide (TMZ), a standard chemotherapeutic drug21. The gene discussed is MGMT; the disease is neoplasm.